document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution copy style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign align center style border solid padding left padding right style margin margin bottom font size font family time roman align center confidential material omitted filed separately with style margin margin bottom font size font family time roman align center security exchange commission double asterisk denote omission table style margin margin bottom font size font family time roman align center companion diagnostics style margin margin bottom font size font family time roman align center master collaboration agreement style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign between valign bottom valign tokai pharmaceutical style font family time roman font size valign valign bottom valign broadway floor style font family time roman font size valign valign bottom valign cambridge style font family time roman font size valign valign bottom valign hereinafter tokai style font size height height colspan style font family time roman font size valign valign bottom valign qiagen manchester limited style font family time roman font size valign valign bottom valign skelton house lloyd street north style font family time roman font size valign valign bottom valign manchester style font family time roman font size valign valign bottom valign england style font family time roman font size valign valign bottom valign hereinafter qiagen table style margin margin bottom font size font family time roman whereas style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign tokai world wide operating pharmaceutical company engaged research development manufacture commercialization pharmaceutical product method treatment patient with pharmaceutical product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign qiagen global provider sample assay technology including vitro diagnostics companion diagnostics relation pharmaceutical industry table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party hereby wish establish legal framework their project specific collaboration field development commercialization vitro diagnostics companion diagnostics tokai compound table style margin margin bottom font size font family time roman therefore party agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign many term defined within provision this agreement convenience following term defined front throughout agreement table style margin margin bottom margin left font size font family time roman activity shall mean activity schedule performed either party connection with particular project style margin margin bottom margin left font size font family time roman affiliate shall mean entity which directly indirectly through more intermediary control controlled under common control with party case used this definition control shall mean possession power direct cause direction management policy entity whether through ownership outstanding voting security contract otherwise style margin margin bottom margin left font size font family time roman agreement shall mean this master collaboration agreement style margin margin bottom margin left font size font family time roman background intellectual property shall mean intellectual property which existence controlled party effective date respective schedule style page break before always size style color width align center style margin margin bottom margin left font size font family time roman business mean other than saturday sunday bank holiday public holiday boston massachusetts style margin margin bottom margin left font size font family time roman clinical trial shall mean clinical investigation tokai product undertaken supported tokai part development such pharmaceutical product obtain information relating patient outcome selection therapy with such pharmaceutical product which clinical investigation includes qiagen prototype developed respective project style margin margin bottom margin left font size font family time roman commercialization commercialize shall refer activity undertaken relating manufacture commercial sale product planning marketing distribution sale tokai product qiagen process commercialization respectively clarification this excludes development regulatory activity style margin margin bottom margin left font size font family time roman confidential information shall mean confidential proprietary information party relating assay diagnostic biomarker genetic sequence compound research project work process future development scientific engineering launch manufacturing marketing business plan financial personnel matter relating such party present future product sale supplier customer employee investor business including result arising from this agreement whether oral written graphic electronic form that disclosed behalf party another party becomes known party consequence performing activity under this agreement notwithstanding foregoing tokai shall disclosing party with respect clinical data biomarker data tokai background intellectual property tokai foreground intellectual property qiagen shall disclosing party with respect analytical performance data qiagen background intellectual property qiagen foreground intellectual property each case regardless party that actually discloses such information style margin margin bottom margin left font size font family time roman control controlled controlling shall mean with respect item intellectual property possession other than operation this agreement right whether directly indirectly whether ownership license otherwise assign grant other party access license sublicense such intellectual property provided herein without violating term agreement other arrangement with third party style margin margin bottom margin left font size font family time roman data shall mean data result conclusion report other information generated tokai resulting from activity performed under project style margin margin bottom margin left font size font family time roman deliverable shall mean data material provided tokai qiagen connection with particular project style margin margin bottom margin left font size font family time roman development project shall mean project performed under this agreement agreed between party schedule development project include nbsp biomarker identification validation nbsp prototype assay development nbsp companion diagnostic proof concept nbsp vitro diagnostic development nbsp enrolment assay style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman development nbsp clinical trial support regulatory consultation nbsp support regulatory submission tokai product which project ultimately result creation commercialization qiagen market under this agreement style margin margin bottom margin left font size font family time roman effective date shall mean date which this agreement been signed both party style margin margin bottom margin left font size font family time roman shall mean european union style margin margin bottom margin left font size font family time roman foreground intellectual property shall mean intellectual property arising from work performed under project during term whether conceived discovered reduced practice writing generated developed employee consultant contractor agent tokai affiliate employee consultant contractor agent qiagen affiliate solely jointly clarification foreground intellectual property shall exclude data style margin margin bottom margin left font size font family time roman governmental authority shall mean court agency authority department regulatory body other instrumentality government country national federal state provincial regional county city other political subdivision such government supranational organization which such country member style margin margin bottom margin left font size font family time roman indication shall mean disease syndrome condition which product used treatment prevention such condition which subject separate regulatory approval style margin margin bottom margin left font size font family time roman intellectual property shall mean intellectual property right including patent right pending issued know material method process protocol invention discovery whether patentable utility model registered design design right copyright copyright registration trade secret other confidential information similar intellectual property right style margin margin bottom margin left font size font family time roman shall mean vitro diagnostic medical device defined european directive avoidance doubt term includes companion diagnostics pharmaceutical product defined guidance industry food drug administration staff vitro companion diagnostic device dated august nbsp style margin margin bottom margin left font size font family time roman major market shall mean united state japan canada australia unless otherwise agreed project schedule style margin margin bottom margin left font size font family time roman market shall mean country world which applicable tokai product commercialized style margin margin bottom margin left font size font family time roman material shall mean biological sample compound reagent supply product other good that tokai delivers qiagen qiagen procures from third party purpose performing this agreement modification derivative such material style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman party shall mean tokai qiagen context requires party shall mean both tokai qiagen style margin margin bottom margin left font size font family time roman project shall mean development project performed under this agreement subsequent commercialization respective qiagen style margin margin bottom margin left font size font family time roman qiagen domain name shall mean domain name identical similar with qiagen trademark under cctld country code level domain gtld generic level domain address area style margin margin bottom margin left font size font family time roman qiagen shall mean developed qiagen course project including respective development stage style margin margin bottom margin left font size font family time roman qiagen platform shall mean diagnostic instrumentation device firmware base software user interface software which include example qiasymphony instrument style margin margin bottom margin left font size font family time roman qiagen trademark shall mean trademark which qiagen commercialization qiagen used connection with tokai product style margin margin bottom margin left font size font family time roman regulatory approval shall mean with respect regulatory jurisdiction approval product establishment license registration authorization governmental authority necessary commercial manufacture storage import export transport commercialization product such regulatory jurisdiction including where applicable nbsp pricing reimbursement approval such regulatory jurisdiction nbsp post approval marketing authorisation including prerequisite manufacturing approval authorisation related thereto nbsp labelling approval nbsp technical medical scientific licence with regard regulatory approval would occur upon approval premarket approval application novo classification premarket authorization similar approval governmental authority other jurisdiction style margin margin bottom margin left font size font family time roman regulatory submission shall mean with respect regulatory jurisdiction submission which necessary obtain regulatory approval style margin margin bottom margin left font size font family time roman schedule shall mean attachment executed party under this agreement described section nbsp which detail project containing list activity tokai compound deliverable market other term applicable development project style margin margin bottom margin left font size font family time roman tokai compound shall mean single biological chemical substance identified schedule that tokai developing commercializing prevention treatment palliation cure disease syndrome condition human animal style margin margin bottom margin left font size font family time roman tokai domain name shall mean domain name identical similar with tokai trademark under cctld country code level domain gtld generic level domain address area style margin margin bottom margin left font size font family time roman tokai product shall mean product containing tokai compound style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman tokai trademark shall mean trademark which tokai commercialization tokai product with which qiagen will used style margin margin bottom margin left font size font family time roman trademark shall mean tokai trademark qiagen trademark style margin margin bottom margin left font size font family time roman valid claim shall mean claim granted patent tokai product that nbsp lapsed expired been disclaimed nbsp that been revoked held invalid otherwise declared unenforceable final judgment court tribunal patent authority competent jurisdiction from which appeal taken claim patent application that been nbsp abandoned disclaimed nbsp finally rejected disallowed appropriate administrative agency court competent jurisdiction from which appeal taken nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign other definitional interpretative provision word hereof herein hereunder word like import used this agreement shall refer this agreement whole particular provision this agreement caption herein included convenience reference only shall ignored construction interpretation hereof capitalized term used schedule otherwise defined therein shall have meaning defined this agreement singular term this agreement shall deemed include plural plural term singular whenever word include includes including used this agreement they shall deemed followed word without limitation whether they fact followed those word word like import except where context otherwise requires word used inclusive sense connoted term this agreement will fairly interpreted accordance with term without strict construction favor against either party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign project table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign schedule generally this agreement shall govern project identified under schedule period during which project initiated hereinafter initiation term under this agreement five nbsp year effective date until terminated accordance with section nbsp qiagen shall perform activity provide deliverable forth relevant schedule this agreement accordance with highest prevailing standard care skill reasonably expected field developing commercializing vitro diagnostics companion diagnostics including adherence applicable cglp with respect tokai product developed animal cgmp cgcp practice additional requirement forth schedule qiagen shall comply with reasonable applicable guideline instruction that tokai provides writing regarding storage handling patient sample tokai product qiagen shall responsible quality technical accuracy completeness deliverable generated provided under this agreement schedule qiagen shall responsible professional quality training supervision affiliate permitted subcontractor personnel engaged performance activity project under schedule qiagen will perform foregoing obligation good faith using commercially reasonable diligent effort meet milestone forth each schedule table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign negotiation schedule each project conducted under this agreement party shall negotiate specific detail execute separate written schedule each schedule shall detail inter alia scope activity tokai compound deliverable project time line market compensation term throughout term project each schedule subject scope change agreed accordance with section once executed both party each schedule amendment schedule shall incorporated entirety into this agreement party shall obliged enter into schedule virtue this agreement qiagen shall obligated perform activity tokai until party have executed schedule that project table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign scope change each time that party agree that activity deliverable project should amended additional activity deliverable should added project party shall prepare written amendment schedule such project party shall vary from activity deliverable original schedule until party have agreed writing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign conflicting provision event there specific conflict between term condition this agreement term condition schedule term condition this agreement shall govern unless schedule specifically expressly supersedes this agreement specific matter then only with respect particular schedule matter specified table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign material record table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign material delivery more specifically provided each schedule tokai shall without undue delay provide relevant material free charge qiagen qiagen considers that material provided tokai conform their specification then nbsp qiagen shall provide tokai written notice hereof explaining detail material conform nbsp case party agree such conformance tokai shall nbsp provide replacement material nbsp that possible propose discus with qiagen good faith alternative amend schedule writing reflect such alternative case party disagree question conformance material party will discus this matter agree good faith solution extent tokai request that qiagen procure material directly from relevant vendor such procurement subject handling charge agreed party advance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size restriction qiagen shall handle material accordance with applicable documentation reasonable handling procedure similar material applicable common scientific standard care tokai written instruction qiagen undertakes material only connection with activity described applicable schedule other purpose qiagen shall material accordance with applicable none material shall transferred sold third party except subcontractor approved tokai qiagen shall material testing table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign treatment human subject except extent described applicable schedule qiagen understands agrees that material experimental nature that tokai shall liable loss claim damage liability which arise from storage handling material qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign audit during following term tokai retains right audit have audited qiagen record other documentation facility relation development regulatory activity project more than time twelve nbsp month period during term unless there arises material quality issue that impact project cause audit tokai qiagen agrees maintain accurate detailed record information pertaining particular project agrees grant access tokai nominee other governmental authority market qiagen other project related facility upon request such audit will require reasonable prior written notice than other than case cause audit tokai subject commercially reasonable security safety procedure should food drug administration european medicine agency other governmental authority market conduct give notice intent conduct inspection investigation site take other action with respect project excluding routine audit facility qiagen will promptly give tokai notice thereof supply information finding pertinent thereto table style margin margin bottom margin left font size font family time roman audit performed within qiagen internal program result critical major finding concerning project qiagen shall provide tokai with summary such finding proposed corrective action following completion such audit should other governmental authority conduct give notice intent conduct inspection qiagen office other qiagen facility relating development regulatory activity project excluding routine audit facility qiagen will promptly longer than hour give tokai notice thereof supply information finding which have adverse impact tokai compound tokai product qiagen project tokai clarification excluding information relating third party project compound prior responding finding aforementioned inspection qiagen shall review discus such response with tokai inspection relates solely qiagen project tokai extent permitted tokai shall entitled have representative present such inspection interaction with other governmental authority with respect thereto style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign financial record qiagen agrees maintain period seven nbsp year after expiration termination this agreement adequate record copy receipt third party expense incurred connection with performance activity allow access tokai authorized representative inspect such record receipt upon reasonable notice during ordinary business hour subject qiagen generally applicable security safety procedure table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign interaction with affiliate third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subcontractor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign either party involve affiliate performance project without notice consent from other party involvement third party contractor either party performance development project under schedule requires prior written consent other party such consent unreasonably withheld foregoing shall construed preventing either party from using individual consultant table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign extent that party utilizes affiliate third party contractor perform task within scope project such party shall ensure such affiliate third party contractor obligated nbsp treat other party confidential information accordance with provision section nbsp nbsp assign right foreground intellectual property material data that such right conveyed accordance with term condition section nbsp nbsp with respect qiagen that affiliate third party contractor grant audit inspection right similar right forth section nbsp whereas foregoing shall limit qiagen audit inspection responsibility each party shall liable solely responsible performance compensation respective third party contractor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign contract laboratory party third party contract laboratory performance certain service such sample testing pursuant schedule hereinafter contract laboratory tokai qiagen shall cooperate reasonably case case basis when contracting with such contract laboratory absence agreement under schedule contrary however tokai shall responsible authorized select contract contract laboratory engaged clinical utility qiagen subject qiagen prior consent which only withheld case qiagen reasonable quality concern with respect performance such sample testing such contract laboratory tokai qiagen shall ensure that contract laboratory properly certified clinical utility work according applicable schedule project this agreement qiagen shall solely responsible manufacture supply qiagen contract laboratory clinical utility testing sufficient educating training contract laboratory personnel necessary conducting clinical utility testing qiagen also shall responsible ensuring that each such contract laboratory provided necessary equipment including upgrade needed perform assay developed hereunder which shall tokai expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign invoice tokai shall qiagen accordance with payment provision forth applicable schedule party hereby agree that project shall performed basis milestone based structure unless agreed otherwise payment made dollar wire transfer bank account specified qiagen schedule qiagen shall issue invoice payment which milestone based upon their completion accordance with this agreement relevant schedule addition qiagen shall issue separate invoice each month reimbursable expense forth section nbsp which accrued relevant month invoice shall sent following address table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center tokai pharmaceutical style margin margin bottom font size font family time roman align center broadway floor style margin margin bottom font size font family time roman align center cambridge style margin margin bottom margin left font size font family time roman mentioning john mcbride respective project reference line tokai shall such invoice within receipt relevant invoice style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reimbursable expense addition payable under section nbsp tokai shall reimburse direct pocket cost reasonably incurred qiagen labelled through cost schedule without mark surcharge unless otherwise agreed party writing advance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign currency conversion table style margin margin bottom margin left font size font family time roman cost reimbursed tokai accordance with section nbsp which were incurred currency other than dollar shall converted into dollar using average fixing exchange rate published bloomberg under function bfix respective currency noon york time applicable calendar quarter business nbsp dollar foreign exchange fixing rate determined bloomberg relevant currency last bloomberg price such data field last shall used instead style margin margin bottom margin left text indent font size font family time roman http market market researcharchive report worl style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign delay payment under this agreement shall such date specified this agreement failure tokai make payment within after date when shall obligate tokai interest payment qiagen interest period shall commence date inclusive payment date exclusive interest shall calculated based actual number interest period divided interest rate annum shall equal rate fixed prior date reset prevailing rate monthly interval thereafter plus premium percent addition tokai fails make undisputed payment under schedule within sixty nbsp after date qiagen shall entitled lieu other remedy hereunder suspend performance under such schedule until undisputed payment made however tokai fails make undisputed payment under schedule within after date qiagen shall entitled treat such failure material breach tokai terminate this agreement immediately long advance notice pursuant section nbsp been provided table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreed remuneration considered value added hereinafter will additionally legally owed applicable jurisdiction payable after receipt proper invoice which meet legal requirement according applicable table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign extent that good service provided hereunder subject sale rental personal property other transaction indirect under payment said tokai responsibility subject applicable exemption entitlement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party required make payment hereinafter paying party other party hereinafter ayee under this agreement shall entitled deduct withhold from amount payable withholding which paying party liable under provision withheld shall treated having been paid paying party payee purpose this agreement paying party shall timely forward receipt certifying payment withholding behalf payee case paying party deduct withholding fulfillment completion payment obligation settlement payee will withholding paying party separately paying party failed deduct withholding still required withholding account payee authority payee shall assist paying party with regard procedure required order obtain reimbursement authority case authority will reimburse withholding paying party payee will immediately refund amount table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information except connection with activity performance this agreement including permitted filing process regulatory approval otherwise permitted either this agreement disclosing party each party shall nbsp confidential information other party nbsp maintain disclosing party confidential information confidence using same degree care that confidential information like importance event using than reasonable care nbsp disclose transfer confidential information disclosing party material which contain such confidential information third party provided however that disclosure shall permitted receiving party employee consultant agent subcontractor those affiliate reasonably require such confidential information purpose this agreement bound obligation confidentiality with respect such confidential information equal those forth this section nbsp each party hereby consent disclosure confidential information other party affiliate other party reasonably requires such confidential information purpose this agreement such affiliate shall treat such confidential information accordance with term this agreement tokai shall also entitled disclose qiagen confidential information only extent directly related development commercialization tokai product combination with qiagen under binder confidentiality restrictive than provision this section nbsp nbsp potential actual commercialization partner tokai product nbsp potential actual source financing acquirer tokai disclosure made pursuant foregoing section nbsp nbsp shall require qiagen prior written consent unless party which tokai making disclosure competitor qiagen described qiagen periodic filing with security exchange commission required security exchange table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information obligation forth section nbsp shall apply information that receiving party demonstrate competent proof nbsp possessed receiving party affiliate prior disclosure development under this agreement nbsp developed receiving party affiliate independently from disclosure development under this agreement case qiagen particularly also without material nbsp becomes later publicly available other than breach this agreement receiving party affiliate nbsp available receiving party affiliate from third party that legally prohibited from disclosing such information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compelled disclosure either party disclose confidential information other party extent required disclosed applicable judicial governmental order provided however that receiving party take reasonable step give disclosing party sufficient prior notice order contest such order request expense disclosing party such request made disclosing party reasonable discretion event receiving party ultimately required disclose such confidential information that receiving party discloses only such portion confidential information required disclosed seek disclosing party request expense protective order protect confidentiality such confidential information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign equitable relief each party agrees that damage adequate remedy breach this article that accordingly either party shall entitled seek injunctive other equitable relief prevent disclosure confidential information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publicity promptly following effective date party shall issue press release form agreed party following such initial press release party hereto issue other press release other public statement announcement concerning term this agreement without other party prior written consent unless such release includes only those fact that were initially released accordance with first sentence this section nbsp addition party hereto shall name trademark logo trade dress another party affiliate publicity press release other form public announcement disclosure without prior written consent such other party notwithstanding foregoing party disclose term existence this agreement required regulation including without limitation applicable security regulation rule regulation security exchange term existence this agreement required disclosed regulation such party will give other party prior written notice disclosure requirement reasonable opportunity review comment what intended disclosed before disclosure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size publication each party shall have right publish present foreground intellectual property portion thereof that control furtherance publication objective confidential discussion with third party publication tokai will responsible control timing scope publication tokai foreground intellectual property qiagen will responsible control timing scope publication qiagen foreground intellectual property publication joint foreground table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign intellectual property must agreed approved party furthermore tokai shall have right publish present qiagen foreground intellectual property portion thereof publication without qiagen prior written consent qiagen shall have right publish present tokai foreground intellectual property portion thereof publication without tokai prior written consent such publication shall subject provision this agreement relating confidentiality disclosure least prior submission publication publishing party shall submit other party review proposed publication other party shall review proposed publication provide comment publishing party within receipt party agree that publishing party request proposed submission date delayed publishing party agrees delay additional order provide comment address concern regarding publication addition upon other party notice publishing party that other party reasonably belief that more patent application should filed which relate foreground intellectual property controlled other party joint foreground intellectual property prior publication publishing party shall delay publication until such patent application have been filed provided that other party will cooperate expeditiously filing such patent application provided further that such delay publication will exceed from date such notice other party publishing party other party belief that publication contains confidential information other proprietary information belonging such party such party will notify publishing party which will remove reference such confidential information proprietary information prior publication presentation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign intellectual property license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign background intellectual property each party acknowledges agrees that other party control certain background intellectual property that relates that party business operation each party further acknowledges agrees that background intellectual property controlled other party shall between party remain exclusive property other party table style margin margin bottom margin left font size font family time roman each party hereby grant other party during term exclusive worldwide licensable transferable royalty free license under background intellectual property relevant project solely extent such license necessary other party carry activity under respective project including subsequent commercialization qiagen qiagen developed respective project with respective tokai product subsequent commercialization tokai tokai product with qiagen under this agreement avoidance doubt party agree that foregoing license provide qiagen right promote commercialize tokai product further avoidance doubt party agree that foregoing license provide tokai with right promote commercialize qiagen laboratory developed test style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman notwithstanding foregoing intellectual property controlled third party included background intellectual property party such intellectual property shall only included into license grant this section nbsp paragraph nbsp other party committed writing comply with relevant term condition agreement with third party nbsp applicable party have agreed writing allocation sharing payment obligation towards third party which result from other party third party intellectual property addition relevant license agreement with such third party requires allocation data foreground intellectual property license deviating from section nbsp controlling party shall inform other party hereof nbsp upon request other party include such third party intellectual property into license grant under this section nbsp party shall negotiate good faith provision deviating from section them forth writing avoidance doubt foregoing shall also apply third party intellectual property acquired pursuant section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign assignment license back data data supplied qiagen tokai generated clinical trial including example patient data generated contract laboratory behalf either both party course project under this agreement generated qiagen using material shall owned follows table style margin margin bottom margin left font size font family time roman tokai shall clinical data which defined derived from material generated behalf either party both party during course performing activity under project schedule tokai shall free clinical data purpose qiagen legal position hereby assigns right title interest such clinical data tokai legal position assign qiagen hereby grant tokai exclusive worldwide irrevocable perpetual fully paid license clinical data purpose qiagen shall promptly provide tokai copy access clinical data held qiagen affiliate related supporting documentation information result analysis with respect qiagen activity under project schedule when such clinical data become available style margin margin bottom margin left font size font family time roman tokai shall biomarker data which defined generated under project generated behalf either party both party during course performing activity under project schedule tokai shall free biomarker data purpose qiagen legal position hereby assigns right title interest such biomarker data tokai legal position assign qiagen hereby grant tokai exclusive world wide irrevocable perpetual fully paid license biomarker data purpose style margin margin bottom margin left font size font family time roman qiagen shall analytical performance data which defined generated behalf either party both party during course performing activity under project schedule qiagen qiagen shall free analytical performance data purpose tokai legal position hereby assigns right title interest such analytical performance data qiagen legal position assign tokai hereby grant qiagen exclusive worldwide irrevocable perpetual fully paid license analytical performance data purpose style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman tokai hereby grant qiagen exclusive world wide royalty free license right reference clinical data biomarker data with right sublicense qiagen affiliate third party developing obtaining regulatory approval manufacturing selling qiagen under development project behalf qiagen sole limited purpose only extent required carry activity under development project subsequent commercialization qiagen developed within development project with tokai product qiagen shall clinical data biomarker data purpose other than permitted this section nbsp long such clinical data biomarker data constitutes confidential information style margin margin bottom margin left font size font family time roman qiagen hereby grant tokai exclusive license right reference analytical performance data sole limited purpose only extent required nbsp carry activity under project nbsp research develop obtain regulatory approval make have made sell offer sale import export commercialize tokai product license shall licensable except tokai affiliate third party researching developing obtaining regulatory approval making having made using selling offering sale importing exporting commercializing tokai product whether alone collaboration with tokai affiliate style margin margin bottom margin left font size font family time roman between party right title interest material shall remain property tokai style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign foreground intellectual property subject section nbsp paragraph party agree that foreground intellectual property shall treated follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign tokai foreground intellectual property tokai shall exclusively right title interest foreground intellectual property relating nbsp improvement tokai background intellectual property nbsp foreground intellectual property other than qiagen foreground intellectual property that made conceived solely employee consultant contractor agent tokai affiliate hereinafter tokai foreground intellectual property tokai hereby grant qiagen exclusive world wide royalty free license with right sublicense under tokai foreground intellectual property solely carry activity under applicable project including subsequent commercialization qiagen developed within project with applicable tokai product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size qiagen foreground intellectual property qiagen shall exclusively right title interest foreground intellectual property relating nbsp improvement qiagens background intellectual property concerning qiagen platform nbsp foreground intellectual property other than tokai foreground intellectual property that made conceived solely employee consultant contractor agent qiagen affiliate hereinafter qiagen foreground table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign intellectual property qiagen hereby grant tokai irrevocable perpetual exclusive world wide fully paid license with right sublicense under qiagen foreground intellectual property carrying activity under respective project commercialize tokai product with nbsp qiagen nbsp solely nbsp event termination this agreement tokai pursuant section nbsp nbsp market which qiagen decline seek regulatory approval qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint foreground intellectual property party shall jointly equal undivided interest foreground intellectual property other than tokai foreground intellectual property qiagen foreground intellectual property that made conceived jointly employee consultant contractor agent tokai affiliate employee consultant contractor agent qiagen affiliate hereinafter joint foreground intellectual property event that jurisdiction requires consent owner owner grant license right under otherwise exploit joint foreground intellectual property each party hereby grant other party affiliate sublicensable right license exploit such joint foreground intellectual property without requirement accounting other than forth this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign protection foreground intellectual property party will inform each other about foreground intellectual property without unreasonable delay after been conceived their employee agent consultant party shall take legally required step ensure effect allocation foreground intellectual property provided section through sole expense party owning foreground intellectual property according section through other party shall provide reasonable assistance necessary documentation declaration perfect right foreground intellectual property document proof chain title each party will provide other party with thirty nbsp prior notice before pursuing patent protection foreground intellectual property allocated according section through tokai shall responsible preparation filing prosecution maintenance tokai foreground intellectual property joint foreground intellectual property qiagen shall responsible preparation filing prosecution maintenance qiagen foreground intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign defence enforcement each party shall promptly notify other party event becomes aware third party activity that constitute infringement intellectual property that subject this agreement third party claim allegation contesting validity enforceability such intellectual property qiagen shall have right obligation control enforce defend worldwide expense intellectual property right qiagen background intellectual property qiagen foreground intellectual property tokai shall have right obligation control enforce defend worldwide expense intellectual property right tokai background intellectual property tokai foreground intellectual property with respect joint foreground intellectual property party will promptly thereafter consult cooperate determine course action which include without limitation commencement legal action party terminate otherwise address such infringement misappropriation misuse defend joint foreground intellectual property table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign patent term restoration party agree cooperate take reasonable action maximize protection available under safe harbor provision united state patent patent application party shall cooperate with each other including without limitation provide necessary information assistance another party reasonably request obtaining patent term restoration supplemental protection certificate their equivalent country territory where applicable foreground intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign trademark table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign tokai shall have sole right select register maintain tokai trademark expense shall retain right title interest such tokai trademark goodwill associated with attached tokai trademark arising thereof tokai affiliate third party licensee shall inure benefit tokai only tokai will authorized initiate discretion legal proceeding against infringement threatened infringement tokai trademark tokai shall responsible registration hosting maintenance defence tokai domain name avoidance doubt tokai allowed register such domain name name host server maintain defend these domain name them website table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign qiagen shall have sole right select register maintain qiagen trademark expense shall retain right title interest such qiagen trademark goodwill associated with attached qiagen trademark arising thereof qiagen affiliate third party licensee shall inure benefit qiagen only qiagen will authorized initiate discretion legal proceeding against infringement threatened infringement qiagen trademark qiagen shall responsible registration hosting maintenance defence qiagen domain name avoidance doubt qiagen allowed register such domain name name host server maintain defend these domain name them website table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party recognize exclusive ownership each other party trademark logotype trade dress furnished such party connection with marketing sale distribution product defined this agreement party shall either while this agreement effect time thereafter register challenge assist others challenge other party trademark logotype trade dress furnished each party connection with marketing product defined this agreement attempt obtain right such name logotype trademark trade dress confusingly similar marketing product defined this agreement other good product notwithstanding that such good product have different dissimilar product defined this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party hereby grant other party exclusive world wide licensable transferable royalty free license under trademark relevant project extent such license necessary other party carry activity under respective project including subsequent commercialization qiagen accordance with section nbsp this agreement qiagen developed respective project with respective tokai product subsequent commercialization tokai tokai product with qiagen under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party intellectual property license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license relevant tokai product table style margin margin bottom margin left font size font family time roman avoidance doubt tokai shall solely responsible discretion expense obtaining maintaining license other right access other third party intellectual property that necessary development manufacture commercialization tokai product including limited treatment decision derived from diagnostic result patient selection stratification biomarkers qiagen agrees cooperate reasonably with tokai assist tokai acquisition license that obligated obtain pursuant section nbsp provided however that such cooperation shall include undertaking financial obligation such payment royalty milestone like unless otherwise agreed between party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license relevant qiagen table style margin margin bottom margin left font size font family time roman qiagen shall solely responsible discretion expense obtaining maintaining license other right access third party intellectual property related style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp style margin margin bottom margin left font size font family time roman nbsp nbsp style margin margin bottom margin left font size font family time roman nbsp style margin margin bottom margin left font size font family time roman extent necessary development manufacture commercialization qiagen such qiagen pursuant this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialization qiagen companion diagnostic supply ivds table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general principle party agree that ultimate goal each project conducted under this agreement commercialization qiagen used connection with tokai product determination whether which extent which country territory tokai product shall commercialized shall within tokai sole discretion extent tokai commercializes tokai product certain country territory qiagen shall commercialize corresponding qiagen each major market commercialize such qiagen such other market included project schedule table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign qiagen commercialization obligation qiagen shall responsible commercialize have commercialized subcontractor qiagen according term condition herein within timeframe forth relevant schedule qiagen shall prepare party acting through shall agree upon commercialization plan commercialization plan launch marketing sale qiagen market accordance with customary commercial practice clarity activity that nbsp outside scope qiagen customary commercial practice nbsp that tailored necessarily connected same activity tokai product party shall mutually agree plan funding such activity commercialization plan each commercialization plan shall among other thing without limiting foregoing qiagen shall commercially reasonable diligent effort nbsp ensure availability qiagen purchase market connection with initiation ongoing treatment patient with tokai product nbsp collaborate with tokai seek necessary reimbursement approval qiagen from governmental authority other third party payors each major market addition while qiagen shall entitled establish price charged qiagen shall price qiagen manner consistent with market norm pricing companion diagnostic product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory approval qiagen shall responsible obtaining maintaining regulatory approval qiagen major market identified tokai project schedule well other market that mutually agreed party project schedule tokai shall responsible obtaining regulatory approval tokai product without limiting foregoing qiagen shall commercially reasonable diligent effort nbsp tokai request permit tokai participate scheduled meeting with governmental authority each major market regarding development tokai product with qiagen nbsp obtain regulatory approval qiagen each major market nbsp support effort tokai obtain regulatory approval tokai product with qiagen each major market table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacture supply ivds qiagen shall solely responsible shall commercially reasonable diligent effort manufacture qiagen ivds qiagen shall manufacture qiagen ivds compliance with cgmp requirement until commercial launch qiagen qiagen shall ensure that adequate supply qiagen ivds prototype made available tokai contract laboratory clinical trial site according term forth schedule subject receiving sufficient notice required quantity from tokai qiagen shall ensure that maintains sufficient inventory each qiagen necessary complete conduct clinical trial applicable tokai product tokai shall cost remaining quantity which used commercialization qiagen qiagen shall responsible transfer qiagen prototype thereof contract laboratory involved clinical trial within commercially reasonable time prior launch tokai product with reasonable advance written notice tokai such launch qiagen will build maintain cost inventory qiagen ivds which shall sufficient satisfy commercialization requirement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialization term viability qiagen table style margin margin bottom margin left font size font family time roman once tokai commercially launch tokai product market that major market qiagen shall make qiagen commercially available that major market commercially reasonable diligent effort commercialize qiagen that major market qiagen shall also commercialize qiagen market other than major market that were agreed project schedule which tokai funded applicable regulatory approval style margin margin bottom margin left font size font family time roman qiagen shall responsible commercializing qiagen each market long there valid claim that particular market commercialization term however qiagen sooner released from this obligation market market basis follows event qiagen reasonably determines that commercially reasonable commercialize qiagen market other than major market being understood that qiagen shall time keep qiagen commercially available major market labelling tokai product such major market requires that administered potential patient prior physician prescribing applicable tokai product qiagen shall provide tokai with twelve nbsp month written notice which notice shall include detailed summary basis therefor during such twelve nbsp month period qiagen shall commercially reasonable effort procure alternative channel distribution make available procure making available qiagen such quantity upon commercially reasonable term each case necessary reasonably enable tokai market tokai product conjunction with qiagen such supply obligation shall expire upon expiration commercialization term style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign management table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint steering committee within after effective date party shall form joint steering committee facilitate transfer information coordinate process related development regulatory approval commercialization tokai product qiagen ivds being subject this agreement shall composed three nbsp representative appointed each party each representative shall appointed replaced time party upon prior written notice other party these representative shall have appropriate experience knowledge ongoing familiarity with project their then current phase table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign responsibility responsibility shall include limited following function table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign facilitating transfer information data related commercialization regulatory approval process table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign facilitating cooperation party when requested provide information support table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign facilitating coordinated interpretation data table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign establishing determine shall operate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign approving each commercialization plan subject execution commercial plan authorized signatory party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign taking such other action specifically allocated party from time time table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign meeting shall meet either person telephonically video conference than once calendar quarter such greater frequency agreed respective committee member meeting shall such location party agree additional representative party from time time invited attend meeting subject other party prior consent which shall unreasonably withheld chair shall alternate between representative tokai representative qiagen decision require approval majority each party representative table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint project team table style margin margin bottom margin left font size font family time roman within after last signature this agreement party will addition form joint project team joint project team which shall responsible facilitating operational task providing update status development project member include shall limited representative with expertise research biology translational medicine clinical regulatory product development each party will designate representative lead such shall meet either person telephone video conference regular basis however least once month style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint project team responsibility table style margin margin bottom margin left font size font family time roman primary responsibility shall include shall limited following function role style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign serving technical lead principal point contact matter forth schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign overseeing project planning progress coordinating activity forth schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign recommending update schedule including tactic risk mitigation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign leading meeting least monthly facilitate review coordinated interpretation data information sharing timeline monitoring table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign facilitating issue resolution team level escalating issue table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign coordinating with alliance manager provide input agenda preparing thoroughly meeting attending meeting ensuring follow action item table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign alliance manager table style margin margin bottom margin left font size font family time roman manage activity under agreement alliance manager each party alliance manager shall appointed each party alliance manager will associated member style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign serve central point contact table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign manage administrative aspect related agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign manage coordinate different activity under contract ensure appropriate communication information among party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign ensure together with that timeline milestone defined appropriately linked with respective payment schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign support resolution conflict table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint commercialization committee least prior date which first regulatory approval tokai product expected party will form joint commercialization team which shall responsible table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign facilitating transfer information coordination process related commercialization tokai product qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign reviewing each commercialization plan prior submission approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign coordinating planned sale marketing activity including launch strategy market sale force activity marketing strategy alignment package insert instruction data sheet marketing material publication training activity reimbursement strategy sharing market research information advisory board opinion leader table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign forecasting measuring sale distribution data ensure adequate supply qiagen each market table style margin margin bottom margin left font size font family time roman shall constituted shall operate determines style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term this agreement shall come into force effective date shall continue until expiration termination project that have been executed within initiation period until this agreement terminated accordance with this article term table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination cause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign material breach table style margin margin bottom margin left font size font family time roman this agreement style margin margin bottom margin left font size font family time roman either party terminate this agreement immediately upon sixty nbsp prior written notice other party commits material breach agreement fails cure such breach within notice period clarity breach that specific project shall serve terminate this agreement shall addressed forth below termination this agreement shall automatically terminate project schedule commercialization plan related agreement that effect unless party agree otherwise writing style margin margin bottom margin left font size font family time roman project style margin margin bottom margin left font size font family time roman either party terminate project schedule commercialization plan case immediately upon sixty nbsp prior written notice other party commits material breach schedule fails cure such breach within notice period style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insolvency bankruptcy either party terminate this agreement schedule immediately written notice other party other party becomes insolvent make made assignment benefit creditor subject proceeding voluntary involuntary bankruptcy instituted behalf against except involuntary bankruptcy which dismissed within ninety nbsp receiver trustee appointed substantially property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination without cause tokai terminate this agreement schedule project reason reason time upon hundred eighty nbsp prior written notice qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign effect termination event termination cause under section nbsp without cause under section nbsp with regard terminated project table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party shall promptly meet prepare close schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tokai shall make final payment qiagen nbsp rata portion future milestone payment where work properly performed toward agreed milestone prior date termination notice nbsp project specific inventory qiagen maintained accordance with this agreement nbsp through cost that were already paid ordered unable cancelled qiagen pursuant schedule otherwise authorized tokai table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon settlement financial obligation tokai qiagen tokai shall have right issue last order within calendar effective date termination qiagen shall transfer tokai within normal lead time quantity ordered after receipt such last order from tokai quantity qiagen ivds ordered tokai enable tokai complete respective clinical trial whereas tokai shall such qiagen ivds price equalling market price qiagen offer third party customer such type ivds table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign license background intellectual property granted either party under this agreement shall terminate terminated project this agreement terminated entirety upon effective date such termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign finally only event termination tokai material breach this agreement qiagen under section nbsp specifically where tokai terminates this agreement without cause bankruptcy insolvency qiagen under section nbsp license data foreground intellectual property granted either party under section shall survive expiration termination this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign wind down cost table style margin margin bottom margin left font size font family time roman event termination cause qiagen under section nbsp termination without cause tokai under section nbsp with regard terminated project tokai shall reimburse qiagen cost winding down project which shall calculated follows amount equal number qiagen personnel were actively engaged performing activity support development project time termination multiplied percentage their time allocated development project that time multiplied daily rate period business from date notice termination until date qiagen personnel reallocated other activity project exceed style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign return material confidential information earlier completion termination particular project this agreement whole except otherwise permitted herein each party shall destroy return other party expense election material confidential information other party party retain copy confidential information other party purpose evidence return destruction material confidential information will affect receiving party obligation observe confidentiality restriction this agreement provision this section nbsp shall apply copy electronically exchanged confidential information made matter routine information technology backup confidential information copy thereof which must stored receiving party according provision mandatory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size survival termination expiration this agreement will relieve either party liability which accrued hereunder prior effective date such termination preclude either party from pursuing right remedy have hereunder table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign equity with respect breach this agreement prejudice either party right obtain performance obligation arising hereunder section material record payment confidentiality assignment license back data qiagen foreground intellectual property joint foreground intellectual property effect termination wind down cost return material confidential information survival disclaimer indemnification liability insurance miscellaneous shall survive termination expiration this agreement addition other provision which their nature understood survive termination expiration this agreement shall survive table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign warranty disclaimer table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general warranty each party hereby represents warrant other party effective date that nbsp corporation duly organized validly existing good standing under applicable rule regulation nbsp obtained necessary consent approval authorization governmental authority both inside outside market other person required obtained connection with this agreement nbsp execution delivery performance this agreement have been duly authorized necessary corporate action part nbsp knowledge right grant applicable right license provided under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign inconsistent agreement each party hereby represents warrant covenant other party that during term project will grant convey third party right license interest intellectual property that inconsistent with right license expressly granted other party under this agreement with respect relevant project table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign debarment prohibited payment each party hereby certifies that will employ otherwise employed used capacity service person nbsp debarred nbsp best respective party knowledge currently subject debarment procedure food drug administration under title united state code section nbsp other competent authority performing activity under this agreement each party further represents warrant that connection with subject matter this agreement nbsp none employee agent officer director foreign official defined foreign corrupt practice nbsp will make accept request payment either directly indirectly money other asset third party where such payment would constitute violation including foreign corrupt practice bribery nbsp regardless legality shall neither make accept request such payment purpose improperly influencing decision action third party nbsp shall report suspected actual violation this section nbsp other party upon becoming aware same table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compliance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall perform work performed part contractual relationship with other party manner consistent with applicable regulation including limited applicable anti bribery antitrust extent related this agreement each party represents warrant that made provided will make provide payment benefit directly indirectly government official customer business partner healthcare professional other person order secure improper benefit unfair business advantage affect private official decision making affect prescription behaviour induce someone breach professional duty standard table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party will immediately report other party writing suspected detected violation above principle connection with other party business such case will cooperate fully with other party reviewing matter event that party belief good faith that other party violated above principle then such party shall have unilateral right terminate contractual relationship with other party with immediate effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign during term nbsp year period following termination expiration this agreement each party through mutually agreeable independent third party auditor upon reasonable advance notice auditing party sole expense shall have right during normal business hour examine review such book record other document material except individual salary information sole purpose verifying whether other party complied with compliance obligation stated this section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign disclaimer representation warranty forth above lieu other warranty representation express implied statutory each party hereby disclaims warranty representation express implied statutory including implied warranty merchantability fitness particular purpose infringement patent trademark other intellectual property right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification liability insurance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size indemnification qiagen qiagen shall defend indemnify hold harmless each tokai affiliate their respective director officer employee agent together with successor assigns foregoing each tokai indemnitee from against third party claim suit action demand judgment collectively claim extent that such claim arise directly indirectly connection with this agreement resultant liability damage settlement penalty fine cost expense including reasonable attorney liability extent that such claim liability arise connection with nbsp qiagen indemnitee negligence willful misconduct nbsp qiagen indemnitee violation applicable rule regulation nbsp breach qiagen representation warranty covenant under article table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign personal injury death caused qiagen storage handling material violation this agreement nbsp personal injury death caused administration qiagen hereunder nbsp infringement third party intellectual property result commercialization qiagen other than third party intellectual property covering biomarkers provided however that qiagen obligation under this section nbsp shall excused extent that such liability arise claim which qiagen indemnitee entitled indemnification under section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification tokai pharmaceutical tokai shall defend indemnify hold harmless each qiagen affiliate their respective director officer employee agent together with successor assigns foregoing each qiagen indemnitee from against claim extent that such claim arise directly indirectly connection with this agreement resultant liability extent that such claim liability arise connection with nbsp tokai indemnitee negligence willful misconduct nbsp tokai indemnitee violation applicable rule regulation nbsp breach tokai representation warranty covenant under article nbsp personal injury death caused administration tokai product nbsp medical malpractice occurring connection with clinical trial tokai product nbsp infringement third party intellectual property result commercialization tokai product alone third party intellectual property covering biomarkers result commercialization qiagen provided however that tokai obligation under this section nbsp shall excused extent that such liability arise claim which tokai indemnitee entitled indemnification under section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign procedure party seeking indemnification under section nbsp section nbsp indemnitee shall notify other party indemnitor upon becoming aware claim that subject indemnification under this article failure provide such notice shall constitute waiver release indemnitee right indemnification except extent that such delay failure materially prejudice indemnitor indemnitor shall have right obligation control defense disposition including without limitation settlement litigation appeal such claim indemnitee shall cooperate reasonably with indemnitor legal representative connection with investigation defense claim liability covered this article indemnitor shall settle indemnified claim hereunder manner that establishes liability part indemnitee without express written consent such indemnitee indemnitor shall have obligation indemnify indemnitee with respect claim settled without prior written consent indemnitor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign limitation damage neither party will liable other indirect incidental consequential special exemplary punitive multiple other similar damage including claim lost profit revenue arising from relating this agreement provided however that this shall limit restrict indemnification right obligation either party with respect third party claim under this article table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insurance during term until completion last project conducted under this agreement each party shall maintain comprehensive commercial general liability insurance program customary diagnostic pharmaceutical company case including product liability insurance with coverage limit than each occurrence aggregate tokai also will maintain clinical trial liability coverage with limit than each occurrence aggregate will name qiagen additional insured insurer utilized confirm coverage within section nbsp shall rated class better best company form satisfactory both party upon request each party will provide other party respective insurance certificate clarification insurance coverage required herein provided through reasonable structure local global insurance program table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign force majeure neither party shall liable failure delay performance under this agreement cause such strike lockout other labor dispute civil commotion sabotage fire flood explosion government other similar cause within reasonable control party affected force majeure event event either party unable perform obligation hereunder force majeure event such party shall promptly notify other party performance hereunder shall promptly resumed after applicable force majeure event been remedied table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notice notice under this agreement shall writing shall sent registered certified mail postage prepaid overnight courier service attention legal department case qiagen attention chief operating officer case tokai each case address respective party forth first paragraph this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign governing dispute table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign formation existence performance validity aspect this agreement shall governed construed respect accordance with state york without regard rule conflict table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size dispute resolution prior arbitration party shall seek informal resolution dispute process shall initiated with written notice party other describing dispute with reasonable particularity followed with written response within calendar receipt notice each party shall promptly designate executive with requisite authority resolve dispute informal procedure shall commence within calendar date response dispute resolved within business date commencement procedure either party proceed binding arbitration without recourse ordinary court according american arbitration association rule seat arbitration shall table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign york york number arbitrator shall three arbitrator shall appointed accordance with rule language used arbitration proceeding shall english arbitration brought enforcement this agreement because alleged dispute breach default misrepresentation connection with provision this agreement successful prevailing party shall entitled recover reasonable attorney other cost incurred therein addition other relief which they entitled notwithstanding anything contrary this section either party sole judgment belief that such breach this agreement could cause irreparable harm such party nbsp will entitled seek equitable relief order avoid such irreparable harm nbsp will required follow procedure forth this section nbsp with respect seeking such relief table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign entire agreement this agreement entire agreement understanding between party regarding subject matter this agreement supersedes prior discussion arrangement agreement whether oral writing which inferred from conduct party including without limitation initiation agreement dated october nbsp between party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign validitv severability invalidity unenforceability provision this agreement shall affect validity enforceability other provision which shall remain full force effect party undertake replace such invalid unenforceable provision valid enforceable provision which accomplishes possible purpose intent invalid unenforceable provision table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign assignment this agreement freely assigned either party affiliate this agreement shall assigned either party third party except nbsp with other party prior written approval which approval shall withheld unreasonably nbsp reason merger acquisition reorganization consolidation successor interest business which this agreement relates other than provided this section nbsp attempt either party effect assignment without consent other party will void without effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign waiver modification agreement waiver amendment modification term this agreement shall valid unless writing signed authorized representative both party failure either party enforce right under this agreement shall construed waiver such right shall waiver either party more instance construed constituting continuing waiver waiver other instance amendment this agreement shall made writing same applies waiver amendment this written form clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign relationship party relationship party that independent contractor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign independent development nothing this agreement will construed restricting either party ability acquire license develop manufacture distribute itself have others acquire license develop manufacture distribute such party similar technology performing same similar function technology contemplated this agreement market distribute such similar technology addition lieu technology contemplated this agreement provided however that such activity such party comply with provision herein table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign execution counterpart this agreement executed number counterpart each which shall deemed original which together shall constitute same instrument signature provided facsimile transmission adobe portable document format sent electronic mail shall deemed original signature table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party beneficiary person other than tokai qiagen their respective affiliate assignee shall deemed intended beneficiary hereunder have right enforce obligation this agreement table style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof qiagen tokai intending legally bound have executed this agreement date indicated below their respective duly authorized representative style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign colspan tokai pharmaceutical valign bottom valign valign bottom valign colspan qiagen manchester limited style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman john mcbride valign bottom valign valign bottom valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman douglas style font family time roman font size valign name valign bottom valign john mcbride valign bottom valign valign bottom valign name valign bottom valign douglas style font family time roman font size valign title valign bottom valign valign bottom valign valign bottom valign title valign bottom valign senior global operation style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign date valign bottom valign january nbsp valign bottom valign valign bottom valign date valign bottom valign style margin margin bottom border bottom solid font size font family time roman nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center companion diagnostics style margin margin bottom font size font family time roman align center project work plan style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign between valign bottom valign tokai pharmaceutical style font family time roman font size valign valign bottom valign broadway floor style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman cambridge style margin margin bottom font size font family time roman hereinafter tokai style font size height height colspan style font family time roman font size valign valign bottom valign qiagen manchester limited style font family time roman font size valign valign bottom valign skelton house lloyd street north style font family time roman font size valign valign bottom valign manchester style font family time roman font size valign valign bottom valign style margin margin bottom font size font family time roman england style margin margin bottom font size font family time roman hereinafter qiagen table style margin margin bottom font size font family time roman this project schedule this schedule dated march nbsp schedule effective date incorporated into master collaboration agreement dated january nbsp between tokai qiagen purpose this schedule describes project conducted under term including without limitation list activity tokai compound galeterone qiagen development timeline deliverable market other term applicable development project project initiated under initiation agreement dated october nbsp initiation agreement which shall superseded this schedule capitalized term used expressly defined this schedule will have meaning given them style margin margin bottom font size font family time roman this schedule divided into following seven nbsp section style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign background table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign activity table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign deliverable table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign timeline table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign assumption requirement table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compensation table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign additional term table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman background style margin margin bottom font size font family time roman party establishes legal framework their collaboration field development commercialization vitro diagnostics companion diagnostics tokai compound style margin margin bottom font size font family time roman tokai wish have qiagen develop commercialize companion diagnostic identify patient carrying androgen receptor exon splice variant castration resistant prostate cancer crpc treatment with tokai compound purpose this schedule qiagen style margin margin bottom font size font family time roman scope this project development qiagen necessary development clinical validation together with tokai compound designated approval commercialization canada australia while japan included within scope this project evolving regulatory landscape this country tokai request party shall negotiate diligently good faith term under which scope this project would expanded include potential commercialization qiagen together with tokai compound japan style margin margin bottom font size font family time roman activity style margin margin bottom font size font family time roman tokai responsibility style margin margin bottom font size font family time roman relation development qiagen tokai shall responsible following style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign tokai shall solely responsible clinical testing galeterone proper qiagen central laboratory connection with such clinical testing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign tokai shall provide qiagen clinical data including sample patient demographic data regarding qiagen well patient outcome data extent such data available necessary reasonably determined qiagen qiagen regulatory filing qiagen planning further qiagen development activity qiagen performance development project tokai will responsible contracting clinical sample testing providing oversight suitable compliant central laboratory clinical testing site laboratory site qiagen will support selection training qualification this vendor clarification notwithstanding provision party expressly agree that tokai shall responsible milestone payment forth below cost forth attachment which relate application regulatory approval qiagen table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign tokai will make reasonable effort provide clinical sample necessary qiagen development verification validation qiagen will work with approved procurement service provider source appropriate sample sample cost will passed through tokai table style margin margin bottom font size font family time roman qiagen responsibility style margin margin bottom font size font family time roman subject without limiting term condition agreement qiagen shall responsible development qiagen follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign qiagen shall lead development submission with center device radiological health cdrh qiagen qiagen shall inform coordinate with tokai cdrh related matter support tokai discussion with center drug evaluation research cder galeterone table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign subject involvement tokai described above qiagen shall responsible design development regulatory approval qiagen accordance with this schedule including development suitable necessary protocol qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign qiagen shall responsible manufacturing supply delivery qiagen including component qiagen subject intellectual property consideration forth section nbsp below table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign qiagen shall responsible preparation documentation site readiness required submission qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign qiagen shall responsible intended applicable package insert pricing reimbursement market access qiagen subject applicable term table style margin margin bottom font size font family time roman deliverable style margin margin bottom font size font family time roman stage feasibility style margin margin bottom font size font family time roman stage development covered under initiation agreement between qiagen tokai which executed october nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman stage clinical trial assay labelled investigational only style margin margin bottom font size font family time roman labelled clinical trial assay with without required style margin margin bottom font size font family time roman stage development validation style margin margin bottom font size font family time roman fourth stage development will cover activity needed development approval assay canada australia this stage will include design verification clinical validation study style margin margin bottom font size font family time roman stage approval product implementation style margin margin bottom font size font family time roman product implementation into will follow approval approval agreement device labelling with cdrh style margin margin bottom font size font family time roman development data used support application will used generate technical file compliance with essential requirement checklist mhra shall notified product under self certification scheme appropriate labeling translation will prepared necessary country accepting mark style margin margin bottom font size font family time roman canada also assumed that data used support application will used complete necessary requirement established health canada successful submission approval product implementation will follow establish product canadian market with appropriate labelling translation necessary style margin margin bottom font size font family time roman australia also assumed that data used support application will used complete necessary requirement established australian therapeutic good administration successful submission approval product implementation will follow style margin margin bottom font size font family time roman contractual milestone description style margin margin bottom font size font family time roman project agreement will delivered completed milestone based model following description provide high level overview work package deliverable acceptance completion style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman milestone assessment technology transfer style margin margin bottom font size font family time roman this milestone will involve site visit preparation evaluation assessment existing work undertaken nbsp associate john hopkins university information exchange style margin margin bottom font size font family time roman evidence milestone achievement short report finding recommendation technology transfer style margin margin bottom font size font family time roman note this milestone completed under initiation agreement style margin margin bottom font size font family time roman milestone design control planning style margin margin bottom font size font family time roman this milestone represents initial activity associated with companion diagnostic development process splice variant inclusive assay style margin margin bottom font size font family time roman this milestone following design control document will signed provided evidence milestone achievement style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone feasibility conversion inclusive splice variant assay qiagen format nbsp formulation rotor gene style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone clinical trial assay build completion including control specification style margin margin bottom font size font family time roman this milestone entail activity required complete development clinical trial assay phase clinical trial assay planned presented cdrh under investigational device exemption application following work package will competed style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman milestone clinical trial testing nbsp nbsp asia style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone completion design input design input lock design nbsp development plan style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone completion assay optimization specification setting style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone prototype batch manufacturing needed assay performance study style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone assay performance study complete style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone assay software available style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone completion verification batch pilot batch style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman milestone system design lock style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone design output design verification lock completion verification style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman milestone approval style margin margin bottom font size font family time roman this milestone will triggered upon successful approval companion diagnostic style margin margin bottom font size font family time roman evidence milestone achievement receipt successful notification letter cdrh style margin margin bottom font size font family time roman milestone product implementation style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman timeline style margin margin bottom font size font family time roman tokai updated gantt chart based start date style font size vertical align nbsp october style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman assumption requirement style margin margin bottom font size font family time roman tokia qiagen each recognize that this schedule been prepared basis number assumption described this section nbsp during course development project change assumption upon which this schedule based require change modify scope project party agree address such change good faith pursuant process provided under section nbsp regulatory style margin margin bottom font size font family time roman required this shall dependent response risk determination document style margin margin bottom font size font family time roman study estimate style margin margin bottom font size font family time roman tokia estimate screening approximately patient enroll total positive patient into clinical trial patient screening selection planned begin soon possible style margin margin bottom font size font family time roman clinical sample style margin margin bottom font size font family time roman tokai will work with john hopkins university other party supply qiagen with clinical sample support development verification assay style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign qiagen will make best effort procure representative sample development analytical validation assay however availability sample containing specific splice variant guaranteed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign qiagen shall held responsible delay caused insufficient supply other issue with third party sample provider table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such sample shall considered through cost shall paid full tokai upon invoice from qiagen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign development specialized sample material cell line containing specific splice variant included this project plan costing development specialized sample material would considered through cost tokai these through cost outlined estimated attachment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign sample from trial need retained purpose bridging study table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman territory style margin margin bottom font size font family time roman territory this development project shall include market listed attachment this schedule style margin margin bottom font size font family time roman milestone payment style margin margin bottom font size font family time roman following milestone deliverable shall completed qiagen satisfaction tokai accordance with term section nbsp payment completed milestone will made accordance with section nbsp with additional process follows nbsp tokai shall approve dispute milestone completion within business receiving qiagen report nbsp tokai agree review milestone four within business receiving qiagen report nbsp tokai fails approve dispute milestone completion within such time period milestone completion shall considered approved nbsp tokai dispute milestone completion party shall work good faith timely resolve dispute style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center description valign bottom nbsp nbsp valign bottom align center style border bottom solid completion date valign bottom nbsp nbsp valign bottom align center style border bottom solid payment style font family time roman font size valign valign bottom nbsp nbsp valign assessment technology transfer valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign design control planning valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign feasibility testing valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height colspan style font family time roman font size valign colspan align center full milestone style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign clinical trial assay build complete control valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign testing valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign testing valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign testing australia valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign design input lock valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign completion assay optimization specification setting valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign prototype batch manufacture valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign performance study complete valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign assay software available valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign completion verification batch pilot batch valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign system design lock valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign design output verification lock completion assay verification valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign approval valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign product implementation valign bottom valign align center valign bottom valign align center style font size height height colspan height colspan height colspan style font family time roman font size valign total valign bottom valign valign bottom valign valign bottom valign align center table style margin margin bottom font size font family time roman style font size vertical align style margin margin bottom font size font family time roman additional term style margin margin bottom font size font family time roman project term style margin margin bottom font size font family time roman project term this project shall commence schedule effective date continue until commercialization obligation expire under section nbsp unless sooner terminated either party under term style margin margin bottom font size font family time roman technology intellectual property consideration style margin margin bottom text indent font size font family time roman circulating tumor cell technology access style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman scope technology access style margin margin bottom margin left font size font family time roman exchange technology access described above notwithstanding anything section nbsp contrary qiagen will grant hereby grant tokai exclusive right have qiagen utilize technology field companion diagnostics tokai compound clarity technology shall considered background intellectual property qiagen under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom margin left font size font family time roman technology access style margin margin bottom margin left font size font family time roman technology access shall qiagen shall invoice tokai this amount promptly upon tokai shall invoice within receipt style margin margin bottom text indent font size font family time roman sublicense style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign license shall mean that certain exclusive license agreement dated january nbsp between john hopkins university tokai copy which attached hereto attachment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign licensed patent licensed know each defined license shall considered tokai background intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign qiagen specifically acknowledges agrees that accepting grant certain license under shall sublicensed under licensed patent licensed know such qiagen shall subject shall assume certain term condition license such agreement amended from time time communicated qiagen those term condition were imposed qiagen itself these term condition include without limitation diligence reporting recordkeeping indemnification maintenance insurance name audit right addition qiagen sublicense licensed patent licensed know sublicensed qiagen without tokai consent qiagen shall also have right prosecute licensed patent defend enforce licensed patent event conflict inconsistency between applicable provision this agreement provision license provision license shall prevail without limiting foregoing qiagen shall subject section license which term incorporated reference herein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign qiagen acknowledges agrees that tokai provide unredacted copy section within this project agreement which strictly related sublicensing third party intellectual property disclose such information related conduct project extent reasonably necessary tokai fulfil reporting obligation under license event tokai required disclose qiagen confidential information order fulfil obligation under license tokai shall provide qiagen with advance notice such disclosure tokai will reasonably consider comment that qiagen have scope such disclosure table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign long qiagen commercializing qiagen shall provide tokai within following completion each calendar quarter written report detailing country country basis aggregate revenue defined license each qiagen during preceding calendar quarter sufficient detail tokai calculate remit royalty under license such report shall considered highly confidential information qiagen shall disclosed used purpose other than calculating royalty obligation under license without limiting foregoing such report shall include sale revenue defined license deduction adjustment that applicable calculation revenue qiagen shall make itself reasonably available answer question that tokai have foregoing royalty report sufficient time tokai fulfill reporting payment obligation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tokai shall responsible timely payment royalty obligation under license tokai shall defend indemnify hold harmless qiagen third party cost claim liability directly resulting from tokai failure make royalty payment under license except extent such failure result qiagen failing fulfil reporting obligation tokai under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tokai shall time comply with license maintain such license full force effect during term this agreement tokai shall defend indemnify hold harmless qiagen third party cost claim liability directly resulting from tokai failure comply with license except extent such failure result qiagen failing fulfil obligation tokai under this agreement table style margin margin bottom font size font family time roman witness whereof qiagen tokai intending legally bound have executed this agreement date indicated below their respective duly authorized representative style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan tokai pharmaceutical valign bottom valign valign bottom valign colspan qiagen manchester limited style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman nbsp valign bottom valign valign bottom valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman douglas style font family time roman font size valign name valign bottom valign valign bottom valign valign bottom valign name valign bottom valign douglas style font family time roman font size valign title valign bottom valign valign bottom valign valign bottom valign title valign bottom valign senior global operation qiagen style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign date valign bottom valign style margin margin bottom border bottom solid font size font family time roman nbsp valign bottom valign valign bottom valign date valign bottom valign march table style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style margin margin bottom font size font family time roman align center territory style margin margin bottom font size font family time roman united state style margin margin bottom font size font family time roman european union style margin margin bottom font size font family time roman canada style margin margin bottom font size font family time roman australia style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman name valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center description valign bottom nbsp nbsp valign bottom align center style border bottom solid payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman sample procurement valign bottom nbsp nbsp valign bottom procurement crpc sample development verification require customized project established with procurement service provider prospectively collect ship sample valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman material valign bottom nbsp nbsp valign bottom oligos extraction reagent valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman gene tube extraction valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman material valign bottom nbsp nbsp valign bottom reagent valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman long oligonucleotides valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman vitro transcript valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman cell line control material valign bottom nbsp nbsp valign bottom procurement culture cell line development valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman development reference method accuracy valign bottom nbsp nbsp valign bottom comparator method required determine sensitivity specificity assay requirement will determined discussion with cdrh valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman material management valign bottom nbsp nbsp valign bottom style margin margin bottom font size font family time roman cover development specification incoming material such sample good receipt labelling database entry internal tracking storage style margin margin bottom font size font family time roman final amount dependent final ptes cost valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman total estimate valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style margin margin bottom font size font family time roman align center registration style margin margin bottom font size font family time roman party expressly agree that tokai shall fund regulatory filing forth this project agreement despite conflicting term style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman territory valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center requirement valign bottom nbsp nbsp valign bottom align center style border bottom solid cost valign bottom nbsp valign bottom colspan align center style border bottom solid preparation valign bottom nbsp valign bottom nbsp valign bottom align center style border bottom solid review clock bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman canada valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman product implementation together with registration activity submission health canada style margin margin bottom font size font family time roman assumes additional data generation valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign month according health canada guidance style font family time roman font size valign nowrap style margin left text indent font size font family time roman nbsp nbsp mark valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman product implementation with registration activity self certification updated filing with notified body style margin margin bottom font size font family time roman assumes additional data generation valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign bottom product nbsp currently self certified style font size margin margin bottom nbsp style margin bottom margin font size font family time roman subject nbsp existing requirement subject change with update they materialize bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman australia valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman product implementation with registrational activity submission australian therapeutic good administration style margin margin bottom font size font family time roman assumes additional data generation valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp valign month according guidance table style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style margin margin bottom font size font family time roman align center license style margin margin bottom font size font family time roman incorporated reference exhibit company annual report form fiscal year ended december nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential proprietary information tokai qiagen style font size margin margin bottom nbsp body html text document